jnj-79032421
mAbexperimental
Clinical trial activity
1 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 9, 2024 (NCT06255665)
Timeline
No events for the selected filters.
Indications
Studied for
Mechanism of action
- MesothelinINHIBITOR
MSLN inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06255665 | Phase 1 | Feb 9, 2024 | — |
Showing 1 of 1 trials
Page 1 / 1